Legato Capital Management’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-824
Closed -$8.28K 608
2024
Q3
$8.28K Hold
824
﹤0.01% 559
2024
Q2
$12.8K Hold
824
﹤0.01% 559
2024
Q1
$18K Hold
824
﹤0.01% 561
2023
Q4
$15.9K Hold
824
﹤0.01% 566
2023
Q3
$15.2K Buy
824
+104
+14% +$1.87K ﹤0.01% 551
2023
Q2
$13.3K Buy
+720
New +$17K ﹤0.01% 570

Other funds holding OPTN

Legato Capital Management's OPTN Position: Q4 2024 in Review

Legato Capital Management sold out of OptiNose (OPTN) in Q4 2024, closing a stake of 824 shares — an estimated $8.28K sold.

Legato Capital Management first reported a position in OPTN in Q2 2023 and held it in 6 quarters. The position peaked at $18K in Q1 2024. 40 funds tracked by Wall St. Rank hold OPTN as of Q4 2024.

  • Legato Capital Management reported no remaining OptiNose position as of Q4 2024 after selling out during the quarter.
  • Legato Capital Management sold 824 OptiNose shares in Q4 2024, an estimated $8.28K.
  • Legato Capital Management first reported a position in OptiNose in Q2 2023 and held it in 6 quarters.
  • Legato Capital Management's OptiNose position peaked at $18K in Q1 2024.
  • 40 funds tracked by Wall St. Rank held OptiNose as of Q4 2024.

Based on Legato Capital Management's 13F filing for Q4 2024, filed 29 Jan 2025.